Nancy Marie Allen LaPointe, PharmD

Adjunct Associate Professor in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail Remote, Raleigh, NC 27607
Email address nancy.allenlapointe@duke.edu

Dr. Allen LaPointe is an Adjunct Associate Professor in Medicine and Faculty Fellow at the Duke-Margolis Center for Health Policy at Duke University.  She is a researcher and cardiovascular clinical pharmacist with extensive experience in health outcomes and health services research, evidence synthesis, and the protection of human research subjects.  Her clinical and research work have been focused on patient safety, predominately in patients with cardiovascular disease.  This includes work in reducing medication errors, improving medication adherence, safely and effectively translating evidence into clinical practice, comparing safety and effectiveness of therapeutics, evaluating risk communication and mitigation strategies, and exploring the interface between health policy and patient safety.  
 

Education and Training

  • M.H.S., Duke University, 2013
  • Pharm.D., Purdue University, 1988

Publications

Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Nancy Allen Lapointe, Alex Cho, and Geoffrey S. Ginsburg. “Patient experiences with pharmacogenetic testing in a primary care setting.” Pharmacogenomics 17, no. 15 (October 2016): 1629–36. https://doi.org/10.2217/pgs-2016-0077.

PMID
27648637
Full Text

Duan-Porter, Wei, Karen M. Goldstein, Jennifer R. McDuffie, Jaime M. Hughes, Megan E. B. Clowse, Ruth S. Klap, Varsha Masilamani, et al. “Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic Pain.” Ann Intern Med 165, no. 3 (August 2, 2016): 184–93. https://doi.org/10.7326/M15-2877.

PMID
27111355
Full Text

Duan-Porter, Wei, Karen M. Goldstein, Jennifer McDuffie, Jaime M. Hughes, Megan Clowse, Ruth Klap, Varsha Masilamani, et al. “MAPPING THE EVIDENCE: INTERVENTION SEX EFFECTS FOR DEPRESSION, DIABETES, AND CHRONIC PAIN.” In Journal of General Internal Medicine, 31:S296–97. SPRINGER, 2016.

Scholars@Duke

Haga, Susanne B., Jivan Moaddeb, Rachel Mills, Mahesh Patel, William Kraus, and Nancy M. Allen LaPointe. “Incorporation of pharmacogenetic testing into medication therapy management.” Pharmacogenomics 16, no. 17 (November 2015): 1931–41. https://doi.org/10.2217/pgs.15.124.

PMID
26555559
Full Text

Duan-Porter, W., K. Goldstein, J. McDuffie, M. Clowse, J. Hughes, R. Klap, V. Masilamani, Nancy Allen LaPointe, and J. W. Williams. “Mapping the Evidence: Sex Effects in High-Impact conditions for Women Veterans - Depression, Diabetes, and Chronic Pain,” September 2015.

Scholars@Duke

Pokorney, S., X. Mi, L. Qualls, B. Hammill, Nancy Allen LaPointe, L. Curtis, and S. Al-Khatib. “Low use of antiarrhythmic medications and beta blockers increasing over time in medicare part d patients with cardiomyopathy and ventricular tachycardia,” S392–93, 2015.

Scholars@Duke

Allen LaPointe, Nancy M., David Dai, Laine Thomas, Jonathan P. Piccini, Eric D. Peterson, and Sana M. Al-Khatib. “Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.” Circ Cardiovasc Qual Outcomes 8, no. 3 (May 2015): 292–300. https://doi.org/10.1161/CIRCOUTCOMES.114.001499.

PMID
25829248
Full Text

Haga, Susanne B., Nancy M. Allen LaPointe, and Jivan Moaddeb. “Challenges to integrating pharmacogenetic testing into medication therapy management.” J Manag Care Spec Pharm 21, no. 4 (April 2015): 346–52. https://doi.org/10.18553/jmcp.2015.21.4.346.

PMID
25803768
Full Text

Pokorney, Sean, Debbie C. Yen, Kristen Campbell, Nancy Allen LaPointe, and Sana Al-Khatib. “RECONSIDERING APPROPRIATE DOFETILIDE DOSING IN WOMEN.” In Journal of the American College of Cardiology, 65:A382–A382. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60382-5.

Full Text

Pages